OncoTartis, Inc.
PrivateLast Round
Series B
Dec 11, 2017
Total Funding Raised
$9.47M
Company Overview
OncoTartis, Inc. is a biotechnology company that develops a novel category of anti-cancer drugs directed against tissue-specific targets for a variety of malignancies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoTartis, Inc. Comparables
Compare OncoTartis, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Remedy Plan Therapeutics | 91% | |
| Alphina Therapeutics | 81% | |
| Theranib Inc. | 74% | |
OncoTartis, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 11, 2017 | ||||
| Grant | Dec 28, 2011 | ||||
| Series A | Feb 17, 2011 |
OncoTartis, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Skolkovo Foundation | Grant |
| Pharmstandard International S.A. | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 28, 2011
$3.47M grant received from Skolkovo Foundation.
- Feb 17, 2011
Completed a Series A funding round.
OncoTartis, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OncoTartis, Inc.'s valuation, stock price, and market status.